OFM
EPIX

Omega Fund Management’s ESSA Pharma EPIX Stock Holding History

Omega Fund Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-328,196
Closed -$597K – 17
2022
Q3 		$597K Hold
328,196
– – 0.22% 18
2022
Q2 		$1.03M Hold
328,196
– – 0.33% 19
2022
Q1 		$2.03M Hold
328,196
– – 0.42% 20
2021
Q4 		$4.66M Hold
328,196
– – 0.66% 18
2021
Q3 		$2.63M Hold
328,196
– – 0.29% 22
2021
Q2 		$9.38M Sell
328,196
-8,673
-3% -$252K 1.06% 15
2021
Q1 		$9.79M Sell
336,869
-368,824
-52% -$8.57M 0.93% 16
2020
Q4 		$8.42M Sell
705,693
-207,000
-23% -$1.46M 1.26% 13
2020
Q3 		$6.1M Sell
912,693
-584,755
-39% -$3.97M 1.65% 9
2020
Q2 		$9.28M Sell
1,497,448
-192,400
-11% -$912K 2.54% 7
2020
Q1 		$6.76M Sell
1,689,848
-20,000
-1% -$101K 2.8% 8
2019
Q4 		$9.4M Hold
1,709,848
– – 2.99% 8
2019
Q3 		$5.76M Buy
1,709,848
+625,000
+58% +$1.54M 1.78% 9
2019
Q2 		$2.66M Hold
1,084,848
– – 0.68% 12
2019
Q1 		$3.7M Hold
1,084,848
– – 1.19% 9
2018
Q4 		$2.28M Hold
1,084,848
– – 1.69% 9
2018
Q3 		$3.26M Hold
1,084,848
– – 1.54% 13
2018
Q2 		$4.12M Hold
1,084,848
– – 3.04% 9
2018
Q1 		$4.12M Buy
1,084,848
+1,000,000
+1,179% +$4.17M 4.05% 8
2017
Q4 		$373K Hold
84,848
– – 0.27% 12
2017
Q3 		$492K Hold
84,848
– – 0.28% 11
2017
Q2 		$933K Hold
84,848
– – 0.58% 10
2017
Q1 		$5.29M Hold
84,848
– – 3.44% 7
2016
Q4 		$3.72M Hold
84,848
– – 3.02% 7
2016
Q3 		$4.67M Hold
84,848
– – 3.56% 6
2016
Q2 		$5.01M Hold
84,848
– – 3.71% 6
2016
Q1 		$5.51M Buy
84,848
+30,303
+56% +$1.98M 3.83% 6
2015
Q4 		$4.64M Hold
54,545
– – 2.58% 7
2015
Q3 		$6.88M Buy
+54,545
New +$7.61M 3.88% 6

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Omega Fund Management's EPIX Position: Q4 2022 in Review

Omega Fund Management sold out of ESSA Pharma (EPIX) in Q4 2022, closing a stake of 328,196 shares — an estimated $597K sold.

Omega Fund Management first reported a position in EPIX in Q3 2015 and held it in 29 quarters. The position peaked at $9.79M in Q1 2021. 45 funds tracked by Wall St. Rank hold EPIX as of Q4 2022.

  • Omega Fund Management reported no remaining ESSA Pharma position as of Q4 2022 after selling out during the quarter.
  • Omega Fund Management sold 328,196 ESSA Pharma shares in Q4 2022, an estimated $597K.
  • Omega Fund Management first reported a position in ESSA Pharma in Q3 2015 and held it in 29 quarters.
  • Omega Fund Management's ESSA Pharma position peaked at $9.79M in Q1 2021.
  • 45 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2022.

Based on Omega Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.